Word

Status

Registered

Status Code

700

Status Date

Tuesday, May 28, 2019

Serial Number

79230436

Registration Number

5759811

Registration Date

Tuesday, May 28, 2019

Mark Type

2

Filing Date

Thursday, January 18, 2018

Published for Opposition

Tuesday, February 12, 2019

Trademark Owner History

Merxin Ltd - Original Registrant

Classifications

9 Vials for scientific purposes being laboratory equipment; Vials for laboratory use; Glass tubes for scientific purposes being laboratory equipment, none of the aforesaid being additive manufacturing devices or 3D devices

5 Pharmaceuticals for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for inhalers, namely, medical pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders structured for delivery into the body by nebulizer, aerosol, or dry powder, via the lungs or via the nasal passageway; Dietary supplements; Pharmaceutical products for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

44 Pharmaceutical compounding services; Pharmaceutical compounding consultation services; Pharmaceutical compounding advisory services; Medical services; Veterinary services; Hygienic and beauty care for animals; Hygienic and beauty care for humans

10 Surgical, medical, dental and veterinary apparatus and instruments, namely, injection devices for administering drugs sold empty; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical syringes sold empty for administering pharmaceuticals; Medical apparatus for introducing pharmaceutical preparations into the human body; Inhalers for medical use; Medical inhalers; Respiratory monitors for medical use; Apparatus for measuring lung function; Spirometers for examining the function of the lungs; Spirometers; Spirometer mouth pieces and tubing; breath gas analyzers for medical diagnostics; Replacement cartridges for medical inhalers sold empty; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of asthma and respiratory diseases

42 Scientific and technological services, namely, research and design in the field of drug delivery via the lungs or via the nasal passageway; Scientific and technological design of new products for others; Advisory services relating to design engineering; Advisory services relating to product testing; Product design and development in the field of drug delivery via the lungs or via the nasal passageway; New product design services, namely, analysis and evaluation of product design; engineering design and consultancy; Professional consultancy relating to medical technology; engineering project management services, not for business purposes; Engineering research; Pharmaceutical research and development services; research and development for the pharmaceutical industry; Research relating to medicines; none of the aforesaid in relation to additive manufacturing services or 3D printing services

The mark consists of a maroon zigzag line with a grey oval placed under the left side of the line.
The color(s) maroon and grey is/are claimed as a feature of the mark.

Trademark Events

Apr 24, 2018

Application Filing Receipt Mailed

Apr 19, 2018

Sn Assigned For Sect 66a Appl From Ib

Apr 20, 2018

New Application Office Supplied Data Entered

Apr 27, 2018

Assigned To Examiner

Apr 28, 2018

Non-Final Action Written

Apr 29, 2018

Non-Final Action (Ib Refusal) Prepared For Review

May 1, 2018

Refusal Processed By Mpu

May 1, 2018

Non-Final Action Mailed - Refusal Sent To Ib

May 20, 2018

Refusal Processed By Ib

Jul 25, 2018

Teas Response To Office Action Received

Jul 25, 2018

Correspondence Received In Law Office

Jul 26, 2018

Teas/Email Correspondence Entered

Aug 1, 2018

Final Refusal Written

Aug 1, 2018

Final Refusal Mailed

Nov 2, 2018

Limitation Of Goods Received From Ib

Dec 13, 2018

Limitation From The Ib - Request Exam Review

Dec 19, 2018

Teas Request For Reconsideration Received

Dec 19, 2018

Correspondence Received In Law Office

Dec 19, 2018

Teas/Email Correspondence Entered

Dec 20, 2018

Examiners Amendment -Written

Dec 20, 2018

Examiner's Amendment Entered

Dec 20, 2018

Approved For Pub - Principal Register

Dec 21, 2018

Examiners Amendment Mailed

Jan 23, 2019

Notification Of Notice Of Publication E-Mailed

Jan 23, 2019

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jan 23, 2019

Notification Of Possible Opposition Sent To Ib

Feb 8, 2019

Notification Processed By Ib

Feb 12, 2019

Published For Opposition

Feb 12, 2019

Official Gazette Publication Confirmation E-Mailed

Mar 8, 2019

Withdrawn From Issue - Managing Attorney Request

Apr 24, 2019

Examiners Amendment Mailed

May 28, 2019

Registered-Principal Register

Jun 14, 2019

Change Of Name/Address Rec'd From Ib

Aug 28, 2019

Final Disposition Notice Created, To Be Sent To Ib

May 28, 2024

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Sep 27, 2019

Final Decision Transaction Processed By Ib

Sep 9, 2019

Final Disposition Processed

Sep 9, 2019

Final Disposition Notice Sent To Ib